AMANDA MAGGART: Open Payments
NPI 1629356191 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$70,386 in 320 payments from 20 companies in 2025. Trend: 2023 $30,608 · 2024 $39,711 · 2025 $70,386
Speaker / faculty: $46,787Travel & lodging: $17,129Food & beverage: $6,259Consulting: $175Education: $36
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 232 | $58,344 |
| Sumitomo Pharma America, Inc. | 37 | $10,725 |
| Dendreon Pharmaceuticals LLC | 10 | $434 |
| Novartis Pharmaceuticals Corporation | 12 | $203 |
| Endo USA, Inc. | 4 | $170 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $87 |
| Boston Scientific Corporation | 1 | $71 |
| Janssen Biotech, Inc. | 4 | $69 |
| Olympus America Inc. | 3 | $54 |
| UROGEN PHARMA, INC. | 2 | $34 |
Products named: INTERSTIM, GEMTESA, PROVENGE, PLUVICTO, XIAFLEX, PYLARIFY, ORGOVYX, AVEED.
Industry payments across OH — which companies pay providers there.
